Cargando…
Stochastic Tunneling of Two Mutations in a Population of Cancer Cells
Cancer initiation, progression, and the emergence of drug resistance are driven by specific genetic and/or epigenetic alterations such as point mutations, structural alterations, DNA methylation and histone modification changes. These alterations may confer advantageous, deleterious or neutral effec...
Autores principales: | Haeno, Hiroshi, Maruvka, Yosef E., Iwasa, Yoh, Michor, Franziska |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694076/ https://www.ncbi.nlm.nih.gov/pubmed/23840359 http://dx.doi.org/10.1371/journal.pone.0065724 |
Ejemplares similares
-
On the Validity of Using Increases in 5-Year Survival Rates to Measure Success in the Fight against Cancer
por: Maruvka, Yosef E., et al.
Publicado: (2014) -
Evolutionary Dynamics of Intratumor Heterogeneity
por: Iwasa, Yoh, et al.
Publicado: (2011) -
A Race between Tumor Immunoescape and Genome Maintenance Selects for Optimum Levels of (epi)genetic Instability
por: Iwami, Shingo, et al.
Publicado: (2012) -
An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer
por: Foo, Jasmine, et al.
Publicado: (2015) -
The Probable Cell of Origin of NF1- and PDGF-Driven Glioblastomas
por: Hambardzumyan, Dolores, et al.
Publicado: (2011)